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Background: Tumescent anaesthesia (TA) is a widely used technique in oncologic surgeries necessitating large
resection margins. This technique produces transoperative and postoperative analgesia, reduces surgical bleeding,
and facilitates tissue divulsion. This prospective, randomised, blind study evaluated the use of TA in bitches
submitted to mastectomy and compared the effect of TA with an intravenous fentanyl bolus. A 2.5-mcg/kg
intravenous fentanyl bolus (n = 10) was compared with TA using 0.275% lidocaine (n = 10) in bitches submitted to
unilateral mastectomy. Sedation was performed by intramuscular (IM) injection of 0.05 mg/kg of acepromazine
combined with 2 mg/kg of meperidine. Anaesthesia was induced with 5 mg/kg of intravenous propofol and
maintained with isoflurane/O2. Heart and respiratory rates; systolic, mean, and diastolic arterial blood pressures;
central venous pressure; SpO2; ETCO2; inspired and expired isoflurane concentrations; and temperature were
measured transoperatively. Visual analogue scales for sedation and pain and the Glasgow composite and
Melbourne pain scales were used for postoperative assessment. The surgeon investigated the quality of the surgical
approach, considering bleeding and resection ability, and the incidence of postoperative wound complications.
Results: The heart rate was lower and the end-tidal isoflurane concentration was higher in dogs treated with
fentanyl than in dogs treated with TA. A fentanyl bolus was administered to 8 of 10 dogs treated with fentanyl and
to none treated with TA. Intraoperative bleeding and the mammary gland excision time were lower in dogs treated
with TA. The maximal mean and individual plasma lidocaine concentrations were 1426 ± 502 ng/ml and 2443
ng/ml at 90 minutes after infiltration, respectively. The Glasgow Composite Pain Scale scores were higher in dogs
treated with fentanyl than in dogs treated with TA until 2 hours after extubation.
Conclusions: Compared with intravenous fentanyl, TA in bitches: may be easily performed in non-inflamed,
ulcerated, adhered mammary tumours; has an isoflurane-sparing effect; improves transoperative and immediate
postoperative analgesia; is apparently safe for use in clinical conditions as evidenced by the fact that it did not
produce any adverse signs or lidocaine plasma concentrations compatible with toxicity; does not modify the
recovery time; and facilitates the surgical procedure without interfering with wound healing.
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Mammary tumours are the most common neoplasia in
dogs, and mastectomy is the most indicated treatment
with the exception of cases of inflammatory carcinoma
and metastases [1]. Mastectomy requires extensive tissue
resection to achieve a safe, wide margin and avoid
recurrence. Under these circumstances, inappropriate
anaesthetic and analgesic techniques may result in
acute and chronic postoperative pain [2]. Thus, effective
transoperative and postoperative analgesia is required.
Complex surgeries require multimodal analgesia,
which is achieved by the combination of peripheral and
central analgesic agents, to produce analgesic synergism
and reduce adverse effects [3]. Regional analgesia, which
is part of multimodal analgesia, reduces the periopera-
tive requirement of anaesthetic and analgesic drugs
and improves postanaesthetic recovery by inhibition of
nociception [4].
The perioperative use of opioids is a traditional prac-
tice in oncology [5]. However, undesirable effects of pure
opioid agonists of particular concern in oncology pa-
tients have been reported, such as immunosuppression,
stimulation of neoplastic cell growth, and increased risk
of tumour metastases [6-9].
Tumescent anaesthesia (TA) is a local anaesthetic
technique used for infiltration of large areas of the body
using large volumes of diluted local anaesthetic solution,
usually combined with vasoconstrictors [10]. In this con-
text, this technique appears to be promising for regional
anaesthesia in cases of mammectomy. Considering the
diluted nature of the solution, large amounts of anaes-
thetic solution may be safely used with little risk of local
anaesthetic-induced toxicity [11]. In addition to provi-
ding analgesia, this technique reduces intraoperative
bleeding [12].
The first local TA solution was reported by Klein in
1987 [13]. Since then, however, the composition has
been modified from that described in the original report,
mostly by changing the lidocaine and adrenaline concen-
trations. TA has been used for several procedures in
human medicine, such as liposuction [13,14]; dermato-
logical [15], mammary [16,17], facial plastic [18], and
vascular [19] surgeries; sentinel node biopsy in melan-
oma [20]; massive resections [21]; and surgical treatment
of burns and burn sequelae in children [22].
The main reported advantages of TA include intraope-
rative [23] and postoperative analgesia [21,23], better
intraoperative haemostasis [14,21], decreased surgical
cost [23], and hydrodissection of tissues, which facilitates
surgery and minimises surgical trauma [21].
A rare reported complication of TA is pulmonary
oedema. Thus, care should be taken to avoid fluid over-
load [10,24]. Care should also be taken with the con-
comitant chronic use of drugs that may slow lidocainebiotransformation and increase lidocaine-induced tox-
icity [25] by inhibiting the cytochrome P-450 isoenzymes
CYP3A4 and CYP1A2, such as benzodiazepines, metro-
nidazole, amiodarone, omeprazole, and verapamil. Other
possible complications of TA are local anaesthetic intra-
vascular injection, increased lidocaine toxicity by the
concomitant use of sedatives [10,12], peri-incisional tis-
sue oedema, risk of seeding neoplastic cells throughout
the surgical site by the mechanical action of the cannula,
and risk of further contamination in cases of skin
infection or ulcers present in the tumours; TA is not
recommended under this last circumstance.
Use of the Klein cannula is indicated for injection of
large volumes of solutions. Its large diameter and pres-
ence of several lateral holes provide greater dispersion of
the solution. The blunt tip also minimises vascular
lesions, thoracic and abdominal penetration, and pain
from injection [26]. A modified closed circuit can be
used for infiltration [27], reducing both the time to per-
form the technique and the risk of infection.
To our knowledge, there is no report of the use of TA
in veterinary medicine. The hypothesis of this study was
that TA produces effective perioperative analgesia with
apparent low toxicity and facilitates and reduces the
mammary gland excision time during mastectomy in
bitches.
The aim of this study was to compare the periana-
esthetic and surgical effects of the use of TA in bitches
submitted to unilateral mastectomy against intravenous
(IV) administration of fentanyl.
Methods
This study was previously approved by the Ethical Com-
mittee on the Use of Animals for Research and Teaching
from the Faculty of Veterinary Medicine and Animal
Science, UNESP, Botucatu, Sao Paulo, Brazil (protocol
number 137/2010). After obtaining the owners’ consent,
20 bitches of different breeds ranging from 5 to 13 years
of age, weighing 13.57 ± 9.57 kg, and classified as ASA I
or II were submitted to unilateral mastectomy for treat-
ment of mammary tumours. Selection criteria were
based on normal complete blood test results, renal and
hepatic function test results, and radiography and ultra-
sonography findings. Animals with metastases; tumours
in other systems; inflamed, ulcerated, or adhered mam-
mary tumours; and tumours of >5 cm in diameter were
excluded.
Water and food were withheld for 6 and 12 hours, re-
spectively, prior to surgery. Sedation was performed with
0.05 mg/kg of acepromazinea combined with 2 mg/kg of
meperidineb intramuscularly. An IV catheter was placed
in the right cephalic vein for administration of saline so-
lution at 20 ml/kg/h. Another catheter was introduced
into the left cephalic vein for collection of blood samples
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ous pressure (CVP) was measured through a CVP cath-
eter inserted in the right jugular vein. Anaesthesia was
induced with 5 mg/kg of propofolc IV followed by endo-
tracheal intubation and was maintained with isofluraned/
O2 using a calibrated vaporiser
e and a rebreathing or
non-rebreathing circuit according to the weight of the
animal (> 7 or < 7 kg, respectively). All animals were
maintained under spontaneous respiration. After 15 mi-
nutes of stabilisation of anaesthesia and monitoring, the
animals were divided in two groups using a randomised,
blind protocol.
Animals were treated with either TA (GT) or IV
fentanylf (GF). TA was performed by introduction of a
Klein cannula (Figure 1) after creation of a small skin in-
cision. The local anaesthetic solution (15 ml/kg at 4°C)
was injected under extension of the target mammary
glands. The tumescent solution was prepared with 250
ml of lactated Ringer’s solution, 40 ml of 2% lidocaine,
and 0.29 ml of adrenaline (1 mg/ml) to achieve a lido-
caine concentration of 2.75 mg/ml (0.275%) and total
lidocaine dose of 41.25 mg/kg. The solution bag was
connected through a three-way tap to a 20-ml syringe in
one end and the Klein cannula in the other end to create
a closed system (Figure 1).
TA was performed with the animal in dorsal recum-
bency, starting in the thoracic region, moving to the
abdominal region, and finishing in the inguinal mammae
(Additional file 1: Video 1). The infusion of the solution
was concomitant with the advancement of the cannula.
Two points of insertion were used: immediately cranial
and caudal to the thoracic and inguinal mammae,Figure 1 Closed circuit used to infiltrate the tumescent solution withrespectively, avoiding the pudendal vessels in the in-
guinal region.
Animals in the GF group received a bolus of 2.5 mcg/
kg of fentanyl IV, diluted to 0.005 mg/ml. Injection was
performed slowly to avoid bradycardia or respiratory de-
pression, and the injection speed was based on changes
in the respiratory and heart rates and end-tidal carbon
dioxide concentration (ETCO2).
After one of the analgesic techniques had been
performed, a drape was placed in the vertical direction
at the cervical region of the animal, to isolate the head
and monitoring equipment from the surgical area and
avoid visual contact of the anaesthetist with the surgical
field. Next, a second anaesthetist (blind) was called
to conduct the anaesthetic procedure. Surgery was
performed by the same experienced surgeon (not blind)
in all cases and started 10 minutes after analgesia had
been completed in each group. The isoflurane concen-
tration was adjusted to provide a sufficient depth of an-
aesthesia as judged by the ocular reflexes and increase in
blood pressure and heart and respiratory rates above
20% when compared with preoperative values. However,
when these changes were observed in direct association
with the surgical stimulus, even when an adequate depth
of anaesthesia was present, the anaesthetist (blind) was
allowed to use IV fentanyl whenever necessary.
The heart and respiratory rates and temperature were
measured before, during, and after anaesthesia, and inva-
sive arterial blood pressure, CVP, oxygen haemoglobin
saturation (SpO2), ETCO2, and inspired and end-tidal
(ETIso) isoflurane concentrations were measured during
anaesthesia using a multiparametric monitor and gasthe detail of the blunt infiltration cannula with side holes.
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analgesia (PA), at the beginning of the first incision (I);
thoracic (TM), abdominal (AM), and inguinal mammary
gland divulsion (IM); pudendal artery and vein clamping
(PAV) and surgical synthesis (S); 15 minutes after surgi-
cal synthesis (S15); and immediately after the end of sur-
gery (ES). Anaesthetic, recovery, and surgical times were
recorded.
After the end of the surgery, 0.1 mg/kg of meloxicam
was injected subcutaneously, and the surgeon classified
bleeding and facility to remove the mammary gland as
increased (3), normal (2), or reduced (1) and difficult (3),
normal (2), or easy (1), respectively.
In animals in the GT group, blood samples were col-
lected at 10, 30, and 90 minutes and at 3 and 6 hours
after TA in lithium heparin tubes for measurement of
the plasma lidocaine concentration. The blood was
centrifuged and the plasma was harvested and stored
at −80°C. The lidocaine concentration was measured by
high-performance liquid chromatography coupled with
mass spectrometry with positive electrospray ionisation,
monitoring the ions resulting from lidocaine fragmenta-
tion. The assay limit of detection (sensitivity) was 0.1
ng/ml, the inter-assay coefficient of variation was 2.05%,
and the recovery rate was 96.5%.
Postoperative pain was investigated using the dynamic
and interactive visual analogue scale (DIVAS), modified
Glasgow Composite Pain Scale (GCPS), University of
Melbourne Pain Scale (UMPS), and von Frey filament
test at extubation; 30, 60, 120, 240, and 360 minutes
after extubation; and 2, 5, and approximately 14 days
after surgery. The surgical wound was also evaluated at
the same time points. Tumour recurrence was followed
every 3 months by phone calls. When the owner
reported any problem, the animals were brought to the
veterinary hospital for detailed evaluation.
Sedation was investigated at the same time points using a
visual analogue scale (VAS). Mammary tumour histopatho-
logical examination was performed in all but one case.
Intraoperative analgesia was accomplished with 2.5
mcg/kg of fentanyl IV when the systolic/mean arterial
blood pressure or heart rate increased above 20% of the
postanalgesia value (PA). Postoperative analgesia was ac-
complished with 0.5 mg/kg of IM morphineh when the
GCPS score was > 3.33 and the sedation score was < 50.
A new analgesic rescue was performed using the same
dose of morphine when the GCPS score was not re-
duced after 30 minutes following the first analgesic
rescue or when the DIVAS, GCPS, or UMPS score was
> 33, > 5 or > 9, respectively.
Statistical analysis was performed using Student’s t test
to compare age, weight, and anaesthetic, surgical, and
recovery times. Analysis of variance was used to investi-
gate differences in parametric variables, followed byBonferroni’s or Tukey’s test to investigate differences in
time in each group and between groups respectively
(intraoperative cardiorespiratory data). The Friedman
and Mann–Whitney tests were used for non-parametric
variables to compare differences in time in each group
and differences between groups, respectively (postopera-
tive pain and sedation data). The chi square and Fisher
tests were used for frequency analysis (bleeding and sur-
gical ease). The level of significance was 5%.
Results and discussion
The intraoperative results are presented as mean and
standard deviation, followed by minimum and maximal
values. The heart rate during the surgical procedure was
significantly higher in the GT group until inguinal mam-
mary gland divulsion (111 ± 16 beats/min; range, 86–160
beats/min) than in the GF group (94 ± 19 beats/min;
range, 38–140 beats/min) during anaesthesia. Bradycardia
(heart rate of <60 beats/min) associated with second-
degree atrioventricular blockade occurred in three animals
in the GF group, but only one animal required atropine.
This is a typical effect observed with the use of fentanyl
and has been previously reported [28].
There were no differences in systolic (SABP), mean
(MABP), and diastolic (DABP) arterial blood pressures
either between groups (SABP: GT, 94 ± 21, 61–166; GF,
98 ± 15, 63–160; MABP: GT, 71 ± 13, 43–106; GF, 73 ±
14, 45–110; DABP: GT, 59 ± 11, 40–90; GF, 61 ± 14,
34–128 mmHg). The majority of cases of hypotension
(7 of 10 versus 4 of 10 in the GF group) were observed
during surgery until abdominal mammary removal. When
the SABP was < 90 mmHg, it returned to satisfactory
levels during anaesthesia once the isoflurane vaporiser set-
ting was reduced and the fluid infusion rate was increased.
The ETIso concentration was 27% higher in the GF
group (1.1 ± 0.2; 0.4–1.45) than in the GT group (0.8 ±
0.2; 0.1–1.2) (p = 0.0001). The ETIso values were higher
in the GF group than in the GT group from the thoracic
mammary gland divulsion (TM) to the end of surgery
(ES). With the exception of the initial bolus, most ani-
mals in the GF group required fentanyl rescue during
surgery (14 fentanyl boluses in 8 of 10 animals), mainly
at the TM and AM time points, while no animals in the
GT group required fentanyl rescue. There are no data
regarding the possible isoflurane-sparing effect of lido-
caine infiltration in dogs; however, the isoflurane-sparing
effect of IV lidocaine has been previously reported in
cats [29] and dogs [30,31]. Considering that the plasma
lidocaine concentration in our study was similar to that
achieved after IV infusion, it may be assumed that TA
produces isoflurane-sparing effects as well. However, this
topic warrants further investigation.
Steagall et al. (2006) [31] reported that the use of a fen-
tanyl bolus (5 mcg/kg) followed by continuous infusion
Table 1 Means ± standard deviations of age, weight, and
surgical and anaesthetic recovery times (in minutes
otherwise stated) in bitches submitted to unilateral
mastectomy under tumescent anaesthesia (GT) or IV
fentanyl bolus (GF) (‡ difference between groups)
Groups
GT GF P value
Age (years) 11.1 ± 2.16 9.7 ± 2.33 0.088
Weight (kg) 14.0 ± 10.43 13.14 ± 8.60 0.79
Total surgery time 77 ± 28 92 ± 28 0.25
Mammary gland excision time 30 ± 22 49 ± 19 0.02‡
Suture time 47 ± 11 43 ± 12 0.51
Time to extubation 6 ± 3 6 ± 3 0.88
Time to raising head 16 ± 21 7 ± 5 0.22
Time to sternal recumbence 45 ± 41 23 ± 18 0.15
Time to standing 105 ± 80 68 ± 51 0.23
Time for removal
of the suture (days)
13 ± 1 14 ± 3 0.68
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diovascular stability during mastectomy in bitches. Short-
action opioid agonists, such as fentanyl, usually produce
respiratory depression [5]. However, there was no increase
in ETCO2 or apnoea in animals in the GF group.
There were no differences in the CVP (GT: 8.5 ± 4.8
cmH2O, GF: 6.5 ± 4.7 cmH2O), SpO2 (GT: 99.7% ±
0.7%, GF: 100% ± 0%) or T (GT: 34.5°C ± 1.2°C, GF
34.4°C ± 1.2°C) between the two groups. Although acute
pulmonary oedema is a reported complication after the
use of TA in humans, this aspect does not seem to be
important in dogs, probably because relatively smaller
injected volumes are used in this species. Hypothermia
(< 37°C) developed in all animals during anaesthesia.
The possible causes and adverse effects of intraoperative
hypothermia have been reported elsewhere [32]. Al-
though more severe hypothermia might be expected in
the GT group because of the infiltration of a cold tumes-
cent solution [33], there were no differences between the
groups, showing that the solution did not intensify
hypothermia. Hypothermia was probably produced by
the sedative and anaesthetics used as well as the time of
anaesthesia, even when basic care was provided for
maintenance of temperature, such as the use of an elec-
tric blanket during surgery. At 240 minutes after
extubation, the temperature of all animals in the GT
group was ≥ 37°C. At 360 minutes, the temperature of
two animals in the GF group was still < 37°C.
The only difference in surgical times between the
groups was the shorter mammary excision time in the
GT group (19 minutes shorter, p = 0.0195) compared
with the GF group (Table 1). This was a result of the
mechanical effect generated by the large volumes of the
infiltrated solution [16,21], generating a ‘divulsion-like’
effect under the mammary tissue and facilitating re-
moval of the tissue in the GT group. However, because
there was no difference in the total duration of surgery,
TA does not appear to be superior to fentanyl in terms
of the time to perform surgery.
The intraoperative bleeding was smaller in the GT
group than in the GF group (p = 0.0012), as previously
reported in TA. This is one of the main advantages of
the TA technique, which is beneficial for liposuction in
humans [14,17] and extensive skin [21,22] and onco-
logical surgeries [16,20] (Figures 2 and 3). Adrenaline
produces vasoconstriction, and the large infiltrated vol-
ume of the solution below the target tissue increases the
hydrostatic pressure on small vessels, minimising bleed-
ing [14]. Subjective evaluation of intraoperative bleeding
was chosen here because objective evaluations, such as
gauze-weighting, would suffer interference due to the
large amount of fluid infiltrated into the tissue when the
tumescent technique is used. This reduced bleeding vol-
ume also contributed to the shorter mammary excisiontime in the GT group, as previously described. When
surgical bleeding is reduced, better visualisation of the
operative area is allowed, and less vessel clamping
(Figures 2, 3, 4 and 5), tissue manipulation, and suture
material are necessary. It is widely known that intrao-
perative bleeding can aggravate the postoperative
prognosis, especially in old patients and patients with
systemic diseases. Bleeding impairs tissue oxygenation
and, in oncological patients, is an important factor for
tumour cell dissemination [34] and immunosuppression
[35]. Although there was no significant difference, seven
animals in the GF group and three in the GT group de-
veloped postoperative seromas that resolved 5 days after
surgery. This demonstrates another potential surgical
advantage of TA.
There were no wound-healing problems or dehiscence
in any animal. Skin sutures were removed when the
healing process was completed (10–14 days after sur-
gery) [36].
The maximal mean plasma lidocaine concentration
was 1426 ± 502 ng/ml at 90 minutes after infiltration.
The maximum individual plasma lidocaine concentration
(2443 ng/ml) was observed at 90 minutes after infiltration.
Peaks were achieved in five animals at 30 minutes, in four
at 90 minutes, and in one at 180 minutes. The lowest con-
centration was 455.2 ng/ml at 10 minutes. In all cases ex-
cept one, peak lidocaine plasma concentrations were
achieved between 5 and 144 minutes after complete mam-
mary gland removal, showing that systemic distribution
has already occurred and biotransformation is relevant
when TA is performed (Table 2 and Figure 6). Based on
these findings, TA should be cautiously performed in ani-
mals with liver disease.
Figure 2 Reduced bleeding during mastectomy in one animal submitted to tumescent anaesthesia.
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signs of toxicity (convulsion) in dogs is 22 ± 7 mg/kg
[37]. Lethal doses range from 28 ± 1 to 76 ± 15 mg/kg
when lidocaine is used as a single IV bolus or cumula-
tive doses, respectively [38]. Several factors influence
local anaesthetic toxicity, such as the time for absorption
according to the local vascularisation, the route and site
of administration, the local anaesthetic concentration,
and association with a vasoconstrictor [39]. A bolus in-
fusion of 4 mg/kg followed by a continuous infusion rate
of 0.3 mg/kg/min of lidocaine induced muscular tremors
after 24 ± 13 minutes. At this point, the plasma lido-
caine concentration was 2.7 ± 1.1 mcg/ml [40]. In our
study, there were no apparent signs of toxicity, even in
the animal with the highest lidocaine concentration,
which was still below the previously reported toxic con-
centration after IV lidocaine infusion [40]. The inclusion
of the vasoconstrictor and the low lidocaine concentra-
tion in the tumescent solution (0.275%) probably
contributed to the apparent lack of toxicity. AnotherFigure 3 Clear visibilization of the pudendal vessels during mastectomimportant factor is that when the mammary tissue is re-
moved, part of the anaesthetic solution is also removed,
reducing further absorption of the local anaesthetic.
Although a considerable dose of lidocaine was used in
our study (41.25 mg/kg), a previous study involving 60
human patients who underwent liposuction used up to
76.7 mg/kg of lidocaine, resulting in a plasma concentra-
tion of 3.6 mcg/ml. The authors concluded that
lidocaine was safe at these dosages when used in low
concentrations (0.05%–0.1%) [11].
The analgesic effect produced by lidocaine has been
well recognised in several clinical and experimental
models. Lidocaine attenuates neuropathic pain in ro-
dents [41], produces thermal antinociception in horses
[42], and provides perioperative analgesia in humans
[43] and dogs [44]. Several mechanisms have been pro-
posed to elucidate the analgesic effects of lidocaine and
may be found elsewhere [45].
In this report, there was no difference in the number
of morphine analgesic rescues (five in the GT group andy in one animal submitted to tumescent anaesthesia.
Figure 4 Visibilization of the pudendal vessels during
mastectomy in one animal submitted to unilateral mastectomy
without tumescent anaesthesia.
Table 2 Individual and mean (standard deviations)
plasma lidocaine concentrations (ng/ml) after tumescent
anaesthesia in bitches submitted to mastectomy
Animal M0 M10 M30 M90 M180 M360
1 0 546.9 576.9 667.1 910.7 593.5
2 0 1148.7 2046.3 1653.8 1425.6 544.6
3 0 824.0 1496.9 1439.9 1109.0 740.8
4 0 651.9 1923.7 2443.0 1669.1 1376.1
5 0 817.6 1792.5 1603.7 1552.0 1263.9
6 0 1226.6 1291.2 1972.9 1476.9 1092.1
7 0 464.4 715.4 1220.3 1030.7 980.6
8 0 628.3 1697.7 1391.5 1273.2 964.5
9 0 1028.2 1414.1 852.0 938.3 822.8
10 0 455.2 463.2 1022.7 672.7 475.9
Mean 0 779.18 1341.79 1426.69 1205.82 885.48
SD 0 278.73 572.13 502.85 323.82 304.77
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the groups. No postoperative rescue analgesia was
performed when sedation was above 50% according to
the VAS because of the major interference of sedation
with the GCPS score. This was only observed at the first
postoperative hour, at which time the scores were
greater than the pre-anaesthetic basal values (p < 0.001)
(Figure 7).Figure 5 Bleeding during mastectomy in one animal submitted to unThe DIVAS pain scores were higher than the corre-
sponding basal values from extubation until 30 minutes
after extubation in both groups (Figure 8).
The greater GCPS scores in GF at 60 minutes after
extubation (p = 0.0494) and the earlier increased UMPS
scores in the GF group (from 30 minutes after
extubation until 360 minutes) than in the GT group
(from 240 to 360 minutes after extubation), compared
with the basal values, suggests that better postoperative
analgesia was attained with TA in the bitches undergoing
unilateral mastectomy in the present study (Figures 9
and 10), however a greater number of animals would be
necessary to increase the power of the statistical tests
and confirm that a better postoperative analgesia would
be provided by TA. Most of the analgesic rescues were
performed 60 minutes after extubation in the GF group









M0 M10 M30 M90 M180 M360
Figure 6 Mean plasma lidocaine concentrations after tumescent anaesthesia in bitches submitted to mastectomy (M0-M360: minutes
after tumescent anaesthesia).
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analgesic effect of fentanyl [28].
The weights of three animals that received analgesic
rescue in the GT group were <10 kg. Low-weight ani-
mals receive less total volumes of tumescent solution
compared with heavier animals. In these cases, the vol-
ume might not be sufficient to cover the complete oper-
ated area in some breeds, such as Dachshunds. Thus,
further dilution of the tumescent solution should be
considered under these circumstances to increase theFigure 7 Box plots of medians, 1st and 3rd quartiles of postoperative
bolus (GF) in bitches submitted to mastectomy. Legend: * Differences f
tion; 30–360, minutes after extubation; 2-14D, days after surgery.volume. However, analgesia may not be satisfactory in
such cases.
Intravenous lidocaine infusion reduced the postopera-
tive morphine consumption in dogs that underwent in-
traocular surgery [44]. Although the plasma lidocaine
concentration was 0.4 mcg/ml during anaesthesia, the
authors suggested that lidocaine induced preventive an-
algesia because the drug was undetectable in the plasma
2 hours after surgery and only 50% of the patients re-
ceived analgesic rescue.VAS for sedation after tumescent anaesthesia (GT) or IV fentanyl
rom basal in each group. Basal – before anaesthesia; Ext – at extuba-
Figure 8 Box plots of medians, 1st and 3rd quartiles of postoperative DIVAS for analgesia after tumescent anaesthesia (GT) or IV
fentanyl bolus (GF) in bitches submitted to mastectomy. Legend: * Differences from basal in each group. Basal – before anaesthesia; Ext –
at extubation; 30–360, minutes after extubation; 2-14D, days after surgery.
Credie et al. BMC Veterinary Research 2013, 9:178 Page 9 of 12
http://www.biomedcentral.com/1746-6148/9/178Lidocaine-induced postoperative analgesia is appar-
ently observed when the plasma lidocaine concentration
ranges from 0.4 to 1 mcg/ml in dogs [44] and from 1 to
3.7 mcg/ml in humans [46,47], providing better postop-
erative outcomes and shorter hospitalisation times [48].
Attenuation of the inflammatory response is the ap-
parent mechanism behind lidocaine-induced analgesia
[49]; however, there was no difference between the two
groups for the Von Frey filament test (Table 3),
suggesting that at least in this study, either hyperalgesia
was not affected by TA or the number of animals was







Figure 9 Box plots of medians, 1st and 3rd quartiles of postoperative
bolus (GF) in bitches submitted to mastectomy. Legend: * Differences f
point. Basal – before anaesthesia; Ext – at extubation; 30–360, minutes afteHistopathological examination was performed in 9 of
10 animals in the GT group and in 10 animals in the GF
group. Malignant neoplasia was found in six and seven
animals from the GT and GF groups, respectively.
Although a short follow-up time elapsed after surgery
(7–17 months), there were no tumour recurrences in
any animal. This finding is beyond the scope of this
study. However, it is well documented that regional
anaesthesia attenuates the surgically induced endocrine
responses and minimises or spares the use of opioids,
improving the immunological response [50]. A reduction




GCPS scores after tumescent anaesthesia (GT) or IV fentanyl
rom basal in each group; ‡ differences between groups at each time
r extubation; 2-14D, days after surgery.
Figure 10 Box plots of medians, 1st and 3rd quartiles of postoperative UMPS after tumescent anaesthesia (GT) or IV fentanyl bolus
(GF) in bitches submitted to mastectomy. Legend: * Differences from basal in each group. Basal – before anaesthesia; Ext – at extubation;
30–360, minutes after extubation; 2-14D, days after surgery.
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morphine depress natural killer cell activity and stimu-
late angiogenesis, cell migration, and cell proliferation in
patients with cancer and therefore increases the occur-
rence of metastasis [6,9]. Thus, pure agonist opioids
should be avoided in patients undergoing oncologic sur-
geries [7,51].
In this respect, regional anaesthesia is preferable to the
use of general anaesthesia or opioids because it has been
shown to reduce tumour recurrence in humans and ro-
dents [52-54]. Lidocaine also inhibits epidermal growth
factor receptor activity [34,55].Table 3 Median and semi-amplitude of Von Frey filament
tests (grams/force) in bitches submitted to unilateral




Basal 300 ± 0 300 ± 0
Extubation 300 ± 0 300,± 145
30 min 300 ± 145 300 ±145
60 min 300 ± 145 10 ± 145
120 min 155 ± 145 10 ± 145
240 min 155 ± 145 10 ± 148
360 min 300 ± 145 10 ± 148
Day 2 300 ± 145 300 ± 145
Day 5 300 ± 0 300 ± 145
Day 14 300 ± 0 300 ± 0Considering that regional anaesthesia improved peri-
operative analgesia and surgical conditions in this study,
and taking into account the potential effect of this tech-
nique in the postoperative prognosis of oncological pa-
tients, TA appears to be a promising technique under
these circumstances.
Conclusions
In conclusion, compared with IV fentanyl, the use of TA
in bitches undergoing unilateral mastectomy: may be
easily performed in noninflamed, ulcerated, or adhered
mammary tumours; produces an isoflurane-sparing ef-
fect; improves transoperative and immediate postopera-
tive analgesia; is apparently safe for use in clinical
conditions as evidenced by the fact that it did not pro-
duce any adverse signs or lidocaine plasma concentra-
tions compatible with toxicity; does not modify the
recovery time; and facilitates the surgical procedure be-
cause of reduced bleeding and a shorter mammary gland
removal time without interfering with wound healing.
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